Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials.

导出 OA

翻译打印收藏纠错

作者： Koutaro,Yokote ^[1] ; Shizuya,Yamashita ^[2] ; Hidenori,Arai ^[3] ; Eiichi,Araki ^[4] ; Mitsunori,Matsushita ^[5] ; Toshiaki,Nojima ^[6] ; Hideki,Suganami ^[7] ; Shun,Ishibashi ^[7]

作者单位： Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan. kyokote@faculty.chiba-u.jp. ^[1] Department of Diabetes, Metabolism and Endocrinology, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan. kyokote@faculty.chiba-u.jp. ^[2] Rinku General Medical Center, 2-23 Ohrai-kita, Rinku, Izumisano-shi, Osaka, 598-8577, Japan. ^[3] National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu-shi, Aichi, 474-8511, Japan. ^[4] Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto-shi, Kumamoto, 860-8556, Japan. ^[5] Medical Affairs Department, Kowa Company, Ltd, 3-4-14 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-8433, Japan. ^[6] Clinical Data Science Department, Kowa Company, Ltd, 3-4-14 Nihonbashi-honcho, Chuo- ku, Tokyo, 103-8433, Japan. ^[7] Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan. ^[8]

关键词 FGF21 Glucose metabolism Liver function Pemafibrate